45
Participants
Start Date
October 8, 2019
Primary Completion Date
November 30, 2027
Study Completion Date
November 30, 2027
Palynziq
Participants will take Palynziq as prescribed by their genetics doctor. In accordance with the Palynziq Risk Evaluation and Mitigation Strategy (REMS) protocol, patients will have their first injection of Palynziq at the Emory Genetics Clinic under the supervision of a physician. After initiating therapy, patients will continue to mail in blood spot filter papers and 3-day dietary records to their clinic providers as standard components of clinical care.
RECRUITING
Emory University Hospital Georgia Clinical Research Center, Atlanta
RECRUITING
The Emory Clinic, Atlanta
Collaborators (1)
BioMarin Pharmaceutical
INDUSTRY
Emory University
OTHER